Literature DB >> 2481664

Augmentation of murine lymphokine-activated killer cell induction by a factor produced by Nocardia rubra cell wall skeleton-stimulated T cells.

I Kawase1, T Shirasaka, T Ikeda, H Hara, Y Tanio, M Watanabe, S Saito, T Masuno, S Kishimoto, Y Yamamura.   

Abstract

Four-hour exposure of C3H/HeN mouse spleen cells to Nocardia rubra cell wall skeleton (N-CWS) before 4-day culture with a suboptimal dose of human recombinant interleukin 2 (rIL 2) augmented the induction of lymphokine-activated killer (LAK) cell activity, whereas the treatment with N-CWS alone induced no cytotoxicity. In accordance with this, the IL 2 binding activity of spleen cells was augmented by combined stimulation with N-CWS and rIL 2. The augmented cytotoxicity was mediated by Thy-1.2+, Lyt-1.1-, Lyt-2.1- and asialo GM1+ cells. Cell cultures in diffusion chambers revealed that N-CWS-treated spleen cells produced a LAK cell induction-helper factor (LAK-helper factor, LHF) when cultured with rIL 2. The LHF production required Thy-1.2+, Lyt-1.1+, Lyt-2.1+ and asialo GM1- cells, and the coexistence of unstimulated accessory cells was also essential for the LHF production. Cells responding to both LHF and rIL 2 to generate LAK activity were Thy-1.2-, Lyt-1.1-, Lyt-2.1- and asialo GM1+. The culture fluid of spleen cells stimulated with both N-CWS and rIL 2 contained no tumor necrosis factor (TNF) activity, and the additional stimulation with N-CWS caused no production of either IL 2 or interferon (IFN). Murine recombinant interleukin 1 alpha (Mu-rIL 1 alpha) could not replace the augmentative effect of N-CWS on LAK cell induction. These results suggest that in the presence of rIL 2, N-CWS stimulates murine T cells to produce LHF that is probably distinct from IL 1, IL 2, TNF and IFN.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481664      PMCID: PMC5917909          DOI: 10.1111/j.1349-7006.1989.tb02265.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


recombinant interleukin 2 biological response modifier colony‐stimulating factor fetal bovine serum 4‐(2‐hydroxyethyl)‐l‐piperazine‐ethanesulfonic acid interferon interleukin 1 interleukin 2 interleukin 4 killer‐helper factor lymphokine‐activated killer LAK‐helper factor macrophage‐activating factor murine recombinant interleukin 1α Nocardia rubra cell wall skeleton natural killer nylon wool peripheral blood lymphocytes tumor necrosis factor
  14 in total

1.  IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.

Authors:  J J Mulé; J A Krosnick; S A Rosenberg
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

2.  Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes.

Authors:  S A Rosenberg; S L Schwarz; P J Spiess
Journal:  J Natl Cancer Inst       Date:  1988-11-02       Impact factor: 13.506

3.  Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha.

Authors:  J K McIntosh; J J Mulé; M J Merino; S A Rosenberg
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

4.  Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.

Authors:  L B Owen-Schaub; J U Gutterman; E A Grimm
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

5.  Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.

Authors:  I Kawase; K Komuta; H Hara; T Inoue; S Hosoe; T Ikeda; T Shirasaka; S Yokota; Y Tanio; T Masuno
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

6.  The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha.

Authors:  A Eisenthal; S A Rosenberg
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

7.  Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells.

Authors:  I Kawase; C G Brooks; K Kuribayashi; S Olabuenaga; W Newman; S Gillis; C S Henney
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

8.  The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.

Authors:  D E Kern; S Gillis; M Okada; C S Henney
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

9.  Enhancement of therapeutic effect of interleukin-2 on spontaneous pulmonary metastases of Lewis lung carcinoma by killer helper factor associated with increased induction of killer activity.

Authors:  K Fukuta; S Sone; M Kitahara; M Okada; T Ogura
Journal:  Jpn J Cancer Res       Date:  1989-06

10.  Synergy of Nocardia rubra cell wall skeleton and interleukin 2 in the in vivo induction of murine lymphokine-activated killer cell activity.

Authors:  I Kawase; K Komuta; T Shirasaka; H Hara; Y Tanio; M Watanabe; S Saito; T Ikeda; T Masuno; S Kishimoto
Journal:  Jpn J Cancer Res       Date:  1989-11
View more
  1 in total

1.  Augmentation of murine lymphokine-activated killer cell cytotoxicity by beta-cyclodextrin-benzaldehyde.

Authors:  Y Kuroki; H Ochiai; M Kurokawa; S Niwayama; C Kishimoto; K Tazawa; M Fujimaki
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.